Print

BioTime (BTX) Issues Open Letter to Shareholders of Geron Corporation (GERN)  
10/18/2012 9:29:16 AM

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) today issued the following letter to the shareholders of Geron Corporation (Nasdaq: GERN) regarding Geron’s stem cell assets:
//-->